Pengdong Gao | Emerging Areas in Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Pengdong Gao | Emerging Areas in Neuroscience | Best Researcher Award

Prof. Pengdong Gao, Communication University of China, china.

Dr. Pengdong Gao is an accomplished Associate Researcher at the National Key Laboratory of Media Convergence and Communication, Communication University of China. His academic journey from Applied Mathematics to Cybernetics and ultimately to a Ph.D. in Measurement Technology laid the foundation for a career deeply rooted in interdisciplinary innovation. With nearly two decades of experience, Dr. Gao has consistently contributed to national and institutional research programs. His primary focus lies in applying AI and deep learning to space weather forecasting, ionogram analysis, image processing, and real-time rendering technologies.

Profile

orcid

 

📘 Early Academic Pursuits

Pengdong Gao’s academic journey began with a solid foundation in mathematical sciences at Tianjin University. He earned his B.Sc. in Applied Mathematics in 2001, followed by an M.Sc. in Operations Research and Cybernetics in 2004. His scholarly commitment culminated in a Ph.D. in Measurement Technology and Instruments, completed in 2007. This progressive academic path reflects a consistent emphasis on analytical precision, systems modeling, and instrumental innovation—laying the groundwork for his later endeavors in computational methods, digital imaging, and space-weather-related research.

🏢 Professional Endeavors

Following his doctoral graduation, Dr. Gao embarked on his research career at the High-Performance Computing Center, Communication University of China, where he served as an Assistant Researcher. By 2009, he transitioned to the Ministry of Education’s Key Laboratory of Media Audio and Video as an Associate Researcher. Since December 2019, he has held the role of Associate Researcher at the National Key Laboratory of Media Convergence and Communication. Across nearly two decades of institutional research, he has contributed to multiple projects focusing on real-time rendering, AI-based communication technologies, and advanced multimedia processing systems.

🧠 Contributions and Research Focus

Dr. Gao’s research lies at the intersection of media technology, artificial intelligence, and space weather. His recent publications in Space Weather journal highlight his pioneering work on ionogram prediction and detection using spatio-temporal neural networks. He has uniquely combined deep learning and image-based techniques to automate the classification of ionospheric phenomena, contributing valuable insights into space-weather forecasting. Beyond atmospheric data modeling, his work also spans areas like depth image matching, digital mural restoration, remote sensing registration, and real-scene 3D modeling—testament to his multidisciplinary proficiency.

🏆 Accolades and Recognition

Though his CV does not list traditional awards, Dr. Gao’s achievements are profoundly reflected in his rich portfolio of granted patents and high-impact publications. His role as principal investigator in two significant national and municipal-level projects underscores peer and institutional recognition. The breadth of his intellectual property—spanning ionospheric analysis systems, digital restoration tools, and deep learning-based image processing—illustrates both technical innovation and societal relevance. These contributions enhance the technological infrastructure of scientific visualization and intelligent media systems in China.

🌍 Impact and Influence

Dr. Gao’s work has shaped multiple layers of scientific and technological development. His contributions to the modeling and detection of ionospheric phenomena have implications for communication stability, satellite navigation, and space weather forecasting. At the same time, his innovations in AI-powered digital tools support applications in cultural preservation, wildlife monitoring, and intellectual property protection. These developments have positioned him as an influential voice in the integration of AI with scientific media applications, pushing the boundaries of what automated systems can achieve in real-time environmental analysis and media convergence.

🧾 Legacy and Future Contributions

Looking forward, Dr. Gao’s trajectory signals continued leadership in integrating artificial intelligence with space and media sciences. His vision bridges theoretical modeling with practical systems—from national R&D programs to media restoration frameworks. The patents he has co-authored reflect a commitment to solving real-world challenges through data-driven innovation. As the field of science communication evolves, Dr. Gao is poised to contribute further to the democratization of complex data through intelligent platforms, ensuring that future technologies are both functional and socially meaningful.

🛰️ Innovation in Space and Media Intelligence

What makes Dr. Gao’s career particularly impactful is his niche synthesis of space-weather science with digital media engineering. His recent leadership in projects like the AIGC New Horizons in Science Communication and the Large-Scale Scene Real-Time Rendering Engine showcases his ability to work across both scientific discovery and media application. By harnessing spatio-temporal GANs and neural rendering techniques, his work is not only improving how we analyze the ionosphere but also how we communicate these findings in accessible, compelling ways to the broader public.

Publication

1. Title: IonoGAN: An Enhanced Model for Forecasting Quiet and Disturbed Ionospheric Features From Predicted Ionograms
Authors: Chu Qiu, Jinhui Cai, Zheng Wang, Pengdong Gao, Guojun Wang, Quan Qi, Bo Wang, Zhengwei Cheng, Jiankui Shi, Yajun Zhu et al.
Year: 2025

2. Title: Ionospheric Response Forecasting and Analysis During Magnetic Storm by a Short-Term Ionogram Prediction Model
Authors: Wang Zheng, Cai Jinhui, Gao Pengdong, Wang Guojun, Shi Jiankui
Year: 2025

3. Title: Prediction of Ionograms With/Without Spread‐F at Hainan by a Combined Spatio‐Temporal Neural Network
Authors: Pengdong Gao, Jinhui Cai, Zheng Wang, Chu Qiu, Guojun Wang, Quan Qi, Bo Wang, Jiankui Shi, Xiao Wang, Kai Ding
Year: 2024

4. Title: Automatic Detection and Classification of Spread‐F From Ionosonde at Hainan With Image‐Based Deep Learning Method
Authors: Zheng Wang, Meiyi Zhan, Pengdong Gao, Guojun Wang, Chu Qiu, Quan Qi, Jiankui Shi, Xiao Wang
Year: 2023

🏅 Conclusion

Dr. Pengdong Gao is a highly deserving candidate for the Best Researcher Award. His remarkable blend of technical depth, innovative problem-solving, and real-world application positions him as a leader in the fusion of artificial intelligence with environmental and media sciences. With ongoing impactful research and a clear trajectory of continued excellence, he not only meets but exceeds the standards typically associated with this prestigious recognition. With minor enhancements in global engagement and academic leadership, his influence is set to expand even further.

 

Soroor Advani | Neuroimaging | Best Researcher Award

Posted on by Neuroscientists

Assist. Prof. Dr. Soroor Advani | Neuroimaging | Best Researcher Award

Assist. Prof. Dr.  Soroor Advani, Shohada Tajrish hospital, affiliated with Shahid Beheshti university of medical sciences,  Iran.

Dr. Soroor Advani is a distinguished Iranian neurologist whose academic brilliance was evident from an early age. With a medical degree and a neurology residency from Tehran University of Medical Sciences, she has consistently ranked among the top in national exams. Currently serving at the Department of Neurology at Shohada Tajrish Hospital, she is also advancing her expertise through a Master’s in Medical Teaching at Shahid Beheshti University of Medical Sciences. Her clinical focus is enriched by a deep interest in neurological education and research, and her ability to integrate both reflects a commitment to excellence in patient care and academic mentorship. She is widely respected for her leadership, organizational capabilities, and influence within the medical community.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Born on May 3rd, 1988, Dr. Soroor Advani demonstrated academic excellence from a young age. Her secondary education at Farzanegan High School in Shiraz, affiliated with the National Organization for Development of Exceptional Talents, laid a solid intellectual foundation. She entered Tehran University of Medical Sciences in 2006, excelling in both theoretical and clinical training. During her medical education, she achieved national distinction by ranking 8th in the pre-internship exam (2012), 11th in the basic sciences national exam (2009), and 55th in the highly competitive university entrance exam (2006). These early milestones reflected her unwavering commitment to medicine and neurological sciences.

🧠 Professional Endeavors in Neurology

Following her M.D., Dr. Advani pursued her neurology residency at the prestigious Tehran University of Medical Sciences from 2014 to 2018. Her clinical expertise matured rapidly during this period, and she was consistently recognized for her diagnostic acumen and patient-centered care. Currently, she is affiliated with the Department of Neurology at Shohada Tajrish Hospital under Shahid Beheshti University of Medical Sciences, where she continues to serve as a dedicated clinician and educator. She has also taken her academic growth further by enrolling in a Master’s program in Medical Teaching, underscoring her dual passion for patient care and academic mentorship.

🔬 Contributions and Research Focus

Dr. Advani’s research and academic contributions reflect her dedication to advancing neurological sciences and education. While her clinical expertise spans a wide spectrum of neurological disorders, she has been especially focused on applying evidence-based methods to improve diagnostic accuracy and therapeutic outcomes. Her ongoing studies in medical teaching also reveal her commitment to elevating neurology education in Iran through modern pedagogical practices. By bridging clinical neurology with education science, she aims to foster a new generation of competent neurologists trained in both clinical reasoning and academic excellence.

🏆 Accolades and Recognition

Dr. Advani’s academic achievements are further amplified by the national recognition she has received throughout her journey. Most notably, she was ranked 3rd in the 65th National Board Exam of Neurology in 2018, a testament to her profound knowledge and skill in the field. Earlier, she ranked 226th in the national residency entrance exam (2014), further proving her consistency across multiple stages of competitive assessment. Each award not only signifies personal excellence but also reflects her role as a role model among her peers and juniors in neurology.

💬 Impact and Influence

Beyond clinical and academic prowess, Dr. Advani is respected for her strong interpersonal skills and leadership in collaborative environments. Her ability to effectively mediate conflicts and coordinate between faculty and staff has made her a key figure in institutional harmony and development. Her influence is especially felt in the mentorship of medical students and neurology residents, who benefit immensely from her structured approach and commitment to teaching.

🌍 Legacy and Future Contributions

As a scholar and practitioner, Dr. Soroor Advani stands at the intersection of neurology, research, and medical education. With plans to expand her research into more innovative and interdisciplinary territories, she is poised to contribute significantly to both national and international neurological communities. Her current pursuit of a master’s degree in medical teaching exemplifies her desire to reform and improve teaching methodologies in clinical neurology, which could reshape how neurology is taught in Iranian medical schools.

✨ Commitment to Lifelong Learning

Driven by an insatiable curiosity and the desire to make a tangible impact on healthcare, Dr. Advani embodies the spirit of lifelong learning. Her career reflects a consistent pattern of growth—both intellectual and professional—and signals great promise for continued contributions in neurology. Whether in the ward, classroom, or research lab, she continues to lead by example, inspiring future neurologists and educators alike.

Publication

COVID-19-related strokes in adults below 55 years of age: a case series
Authors: F Ashrafi, A Zali, D Ommi, M Salari, A Fatemi, M Arab-Ahmadi, B Behnam, …
Year: 2020

2. Photobiomodulation’s potential as a non-invasive therapy for Alzheimer’s disease and minimal cognitive impairment: A 12-week investigation
Authors: M Razzaghi, F Sheibani, N Kimia, Z Razzaghi, Z Chenari, F Ashrafi, …
Year: 2024

3. Transverse myelitis after SARS‐CoV‐2 infection: Report of two cases with COVID‐19
Authors: S Advani, SMM Hosseini, A Zali, D Ommi, A Fatemi, R Jalili Khoshnoud, …
Year: 2021

4. Thigh and leg muscle MRI findings in GNE myopathy
Authors: F Fatehi, S Advani, AA Okhovat, B Ziaadini, H Shamshiri, S Nafissi
Year: 2021

5. Transverse myelitis in COVID-19 patients: Report of two cases
Authors: S Advani, A Zali, D Ommi, A Fatemi, RJ Khoshnoud, F Ashrafi
Year: 2020

6. The value of MUNIX as an objective electrophysiological biomarker of disease progression in chronic inflammatory demyelinating polyneuropathy
Authors: AA Okhovat, S Advani, B Ziaadini, A Panahi, S Salehizadeh, S Nafissi, …
Year: 2022

7. Application of CMAP scan for the evaluation of patients with chronic inflammatory demyelinating polyneuropathy: a prospective study
Authors: AA Okhovat, S Advani, K Moradi, B Ziaadini, A Panahi, S Nafissi, …
Year: 2021

8. Guillain-Barre syndrome in patients with coronavirus disease-2019: Report of six cases and review of literature
Authors: AA Okhovat, B Ansari, H Hemasian, B Haghi-Ashtiani, S Advani, …
Year: 2020

9. Shared signaling pathways and comprehensive therapeutic approaches among diabetes complications
Authors: M Ebrahimi, H Ahmadieh, M Rezaei Kanavi, S Safi, S Alipour-Parsa, …
Year: 2025

10. Abnormalities of brain imaging in COVID-19 patients with neurological symptoms
Authors: S Advani, SMM Hosseini, R Bozorgmehr, A Khameneh-Bagheri, …
Year: 2023

✅ Conclusion

Dr. Soroor Advani exemplifies the ideal blend of clinical proficiency, academic dedication, and educational innovation. Her remarkable achievements, both as a neurologist and as an educator-in-training, position her as a vital contributor to the future of neurology in Iran and beyond. With a legacy built on consistent excellence, compassionate care, and educational reform, Dr. Advani is not only shaping current medical practices but also laying a strong foundation for the neurologists of tomorrow.

Sarah Coulette | Neurogenetics | Best Researcher Award

Posted on by Neuroscientists

Dr. Sarah Coulette | Neurogenetics | Best Researcher Award 

Dr. Sarah Coulette, Hospital Fondation Adolphe de Rothschild, France.

Dr. Sarah Coulette is a highly accomplished French neurologist based at the Rothschild Foundation Hospital in Paris. With a strong academic foundation from Toulouse and Montpellier, she has accumulated over eight years of clinical experience in neurology. Her expertise spans multiple sclerosis, Parkinson’s disease, EMG, and oculomotor disorders, with specialized skills in video-oculography. Dr. Coulette’s research has produced impactful publications and conference presentations, notably in areas such as SCA27B, Susac Syndrome, and cerebral amyloid angiopathy. She is recognized for her translational approach, using imaging and electrophysiological tools to enhance diagnostic precision. Her work stands at the intersection of advanced clinical care, academic leadership, and innovative diagnostics, making her a respected figure in both clinical and research spheres.

Profile

Orcid

 

🎓 Early Academic Pursuits

Dr. Sarah Coulette began her distinguished medical journey in Toulouse, where she obtained her medical degree, establishing a robust foundation in clinical medicine. Her passion for neurology led her to pursue a specialized residency (DES) and internship in Montpellier, an environment known for its excellence in neurological education. During her formative years, Dr. Coulette developed an early interest in neurodegenerative and demyelinating disorders, particularly exploring how clinical presentation aligns with neuroimaging and electrophysiological findings. Her dedication culminated in the successful defense of her medical thesis in 2017, focusing on cerebral amyloid angiopathy-related inflammation—an ambitious and insightful project that was later published and presented at multiple prestigious forums.

🏥 Professional Endeavors

Following her residency, Dr. Coulette further advanced her clinical expertise by joining the Rothschild Foundation Hospital in Paris—an esteemed institution recognized for neurological innovation. There, she completed a competitive fellowship as a Chief Clinical Assistant (CCA), immersing herself in complex neurological diagnostics and patient management. As a practicing neurologist in the Department of Neurology, she now contributes daily to the diagnosis and treatment of conditions such as multiple sclerosis, Parkinson’s disease, and rare neuro-ocular syndromes. Her clinical acumen is further strengthened by her proficiency in electromyography (EMG) and video-oculography, placing her at the forefront of diagnostic neurology.

🧠 Contributions and Research Focus

Dr. Coulette’s research is deeply rooted in translational neuroscience, bridging clinical observation with advanced imaging and electrophysiology. She has made significant contributions to the understanding and diagnosis of disorders such as spinocerebellar ataxia type 27B (SCA27B), Susac Syndrome, and cerebral amyloid angiopathy. Her work on Video-Oculography as a diagnostic tool for SCA27B and her exploration of 4-Aminopyridine’s effects on downbeat nystagmus highlight her focus on functional, patient-centric innovation. Moreover, her investigations into magnetic resonance post-contrast FLAIR imaging in Susac Syndrome reflect her commitment to refining diagnostic accuracy in neuroinflammatory diseases.

🏆 Accolades and Recognition

Dr. Coulette’s academic excellence and research acumen have earned her recognition on both national and international stages. Her poster on SCA27B was presented at the Movement Disorder Society in Philadelphia (2024), and her oral presentation on Susac Syndrome was well received at the European Stroke Organization conference in Göteborg (2018) and SFNV the same year. These accomplishments underscore her credibility as a rising thought leader in neurology, consistently contributing meaningful insights to professional communities and peer-reviewed publications.

🔬 Impact and Influence

With over eight years of clinical experience, Dr. Coulette has become a trusted figure in the French neurology landscape. Her clinical interventions, guided by cutting-edge research and precision diagnostics, have directly improved patient care. Through her publications, she has contributed to broader scientific understanding, enabling other clinicians and researchers to refine their diagnostic frameworks and therapeutic strategies. Her collaborative approach and multidisciplinary knowledge make her an influential contributor to the advancement of neurodiagnostic science.

🧬 Legacy and Future Contributions

Dr. Coulette continues to merge clinical expertise with investigative curiosity, envisioning a future where electrophysiological techniques and neuroimaging tools are seamlessly integrated into personalized treatment pathways. Her ongoing work on demyelinating diseases, particularly multiple sclerosis, promises to shape future therapeutic guidelines. She remains dedicated to fostering clinical research that directly enhances patient outcomes, especially in disorders marked by diagnostic ambiguity. Dr. Coulette’s trajectory suggests a future filled with academic innovation and compassionate care, setting a lasting example for future neurologists.

📚 Knowledge Beyond the Clinic

In addition to her clinical and research commitments, Dr. Coulette engages in academic mentoring and educational initiatives aimed at nurturing the next generation of neurology professionals. She advocates for the practical application of diagnostic technologies in medical training and actively participates in conferences, sharing her insights with both seasoned experts and young trainees. Her role as a clinician-researcher places her at the nexus of academic rigor and medical empathy, embodying a model of neurologic excellence that inspires continuous learning and collaboration.

Publication

  • Title: Diagnosis and Prediction of Relapses in Susac Syndrome: A New Use for MR Postcontrast FLAIR Leptomeningeal Enhancement

  • Authors: S. Coulette, A. Lecler, E. Saragoussi, K. Zuber, J. Savatovsky, R. Deschamps, O. Gout, C. Sabben, J. Aboab, A. Affortit, et al.

  • Year: 2019

 

✅ Conclusion

Dr. Sarah Coulette exemplifies the modern clinician-scientist—deeply engaged in patient care while actively pushing the boundaries of neurological science. Her blend of clinical excellence, research innovation, and academic mentorship positions her as a future leader in neurology. With a clear commitment to improving diagnostic methodologies and patient outcomes, her influence is set to grow both within France and internationally. Dr. Coulette’s journey highlights the vital role of neurologists who not only treat but also discover, teach, and inspire.

Nikolaos Marinakis | Neurogenetics | Best Researcher Award

Posted on by Neuroscientists

Dr. Nikolaos Marinakis | Neurogenetics | Best Researcher Award

Dr. Nikolaos Marinakis,  Laboratory of Medical Genetics, NKUA, Greece.

Dr. Nikolaos M. Marinakis is a highly accomplished Molecular Biologist and Geneticist whose career has been devoted to the diagnosis and molecular analysis of rare genetic disorders. With over a decade of laboratory experience and a strong academic background, he has steadily advanced from early bench research in molecular biology to become a Clinical Laboratory Geneticist and genome analyst. His expertise spans whole exome and whole genome sequencing, variant interpretation, CNV and RNA sequencing analysis, and the clinical application of Next Generation Sequencing. Notably, he has contributed to over 1500 molecular diagnoses in patients with rare diseases and has gained international recognition through the ESHG observership at Radboud University Medical Center. Dr. Marinakis exemplifies scientific excellence, clinical impact, and collaborative innovation in human genetics.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Nikolaos M. Marinakis embarked on his academic journey with a strong passion for understanding human biology at a molecular level. He earned his Bachelor’s degree in Molecular Biology and Genetics from the Democritus University of Thrace (DUTH), where he was actively involved in bench research. His undergraduate thesis focused on the functional characterization of NAT1 polymorphisms in the primate Macaca mulatta, offering an early glimpse into his interest in gene function and enzyme activity. This formative research cultivated his technical proficiency in cloning, site-directed mutagenesis, protein purification, and enzymatic assays—skills that would later become instrumental in his advanced academic and clinical endeavors.

🧬 Professional Endeavors in Genetics

Dr. Marinakis has spent more than a decade immersed in both research and clinical laboratories, gaining broad and deep expertise in molecular diagnostics. His professional foundation was laid at the Laboratory of Medical Genetics at St. Sophia’s Children Hospital, affiliated with the National and Kapodistrian University of Athens (NKUA). Here, he progressed from an MSc student to a PhD candidate and eventually to a Scientific Research Associate. His doctoral research was centered on the use of Next Generation Sequencing (NGS) technologies for diagnosing rare genetic disorders, and his project involved bioinformatic evaluation and functional validation of genomic variants. As a current genome analyst, he supervises Clinical Whole Exome Sequencing, routinely interpreting variants in over 1,500 complex diagnostic cases encompassing neurodevelopmental, nephrological, cardiovascular, and ophthalmological diseases.

🔍 Research Contributions and Focus

Dr. Marinakis’s primary research lies at the intersection of clinical genomics and bioinformatics. His scientific focus is on the molecular investigation of rare monogenic disorders, variant classification, and the integration of novel genomic technologies such as long-read sequencing into diagnostic pipelines. He has also contributed to the development and clinical implementation of molecular assays for both postnatal and prenatal diagnostics. His research continues to unravel the genetic underpinnings of syndromes with previously unknown etiologies, enriching the understanding of human genomic complexity. Through RNA sequencing and CNV analysis, he bridges the gap between genotype and phenotype in a clinical context.

🏅 Accolades and Recognition

In recognition of his significant contributions to human genetics, Dr. Marinakis was awarded a competitive observership by the European Society of Human Genetics (ESHG). This prestigious award enabled him to join the Genome Diagnostics unit at the Radboud University Medical Center in the Netherlands under the mentorship of Professor Christian Gilissen. There, he expanded his expertise in whole genome sequencing, variant annotation, structural variation, and advanced bioinformatic pipelines. His growing recognition as a Clinical Laboratory Geneticist (ErCLG-certified) further underscores his professional standing in Europe’s genetics community.

🧠 Impact on Clinical Genomics

Dr. Marinakis has made a measurable impact on translational medicine by bringing genomic science to the bedside. Through his analysis and interpretation of complex NGS datasets, he has helped diagnose hundreds of patients with elusive genetic conditions, directly improving clinical outcomes and enabling personalized treatment strategies. His ability to convert raw genomic data into meaningful clinical insights has made him a key figure in the field of diagnostic genetics in Greece and beyond. His meticulous approach to variant interpretation, especially in challenging or ambiguous cases, continues to guide clinicians in the decision-making process.

🌍 Influence and Collaboration

A committed collaborator and lifelong learner, Dr. Marinakis maintains strong academic and clinical ties with global institutions. His experiences at NKUA and Radboud UMC have equipped him with a broad international outlook on genomics and rare disease research. He actively contributes to cross-border initiatives and research consortiums focused on data sharing, standardization of bioinformatics pipelines, and discovery of novel disease mechanisms. His LinkedIn presence and professional engagement reflect his dedication to connecting with the wider genetics and biomedical community.

🔮 Legacy and Future Contributions

Looking ahead, Dr. Marinakis is poised to lead initiatives that integrate AI-driven genomic interpretation and third-generation sequencing into clinical practice. He aspires to contribute to national and European genomics strategies aimed at early diagnosis, carrier screening, and reproductive planning. By mentoring younger scientists and continuing to publish translational research, he is building a legacy rooted in both scientific rigor and compassionate care. With his strong foundation and forward-thinking vision, Dr. Marinakis represents a dynamic force in the future of precision medicine and rare disease diagnostics.

Publication

  • Title: Phenotype‐driven variant filtration strategy in exome sequencing toward a high diagnostic yield and identification of 85 novel variants in 400 patients with rare Mendelian disorders
    Authors: NM Marinakis, M Svingou, D Veltra, K Kekou, C Sofocleous, FN Tilemis, …
    Year: 2021

 

  • Title: Germline CNV detection through whole-exome sequencing (WES) data analysis enhances resolution of rare genetic diseases
    Authors: FN Tilemis, NM Marinakis, D Veltra, M Svingou, K Kekou, A Mitrakos, …
    Year: 2023

 

  • Title: Case report: a novel synonymous ARPC1B gene mutation causes a syndrome of combined immunodeficiency, asthma, and allergy with significant intrafamilial clinical heterogeneity
    Authors: I Papadatou, N Marinakis, E Botsa, M Tzanoudaki, M Kanariou, I Orfanou, …
    Year: 2021

 

  • Title: The clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders
    Authors: A Saffari, T Lau, H Tajsharghi, EG Karimiani, A Kariminejad, S Efthymiou, …
    Year: 2023

 

  • Title: Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals
    Authors: DE Layo-Carris, EE Lubin, AK Sangree, KJ Clark, EL Durham, …
    Year: 2024

 

  • Title: De novo variants in RNF213 are associated with a clinical spectrum ranging from Leigh syndrome to early-onset stroke
    Authors: T Brunet, B Zott, V LieftĂźchter, D Lenz, A Schmidt, P Peters, R Kopajtich, …
    Year: 2024

 

  • Title: SDH-deficient renal cell carcinoma: A case report associated with a novel germline mutation
    Authors: V Milionis, D Goutas, D Vlachodimitropoulos, AC Lazaris, I Kyriazis, …
    Year: 2021

 

  • Title: Towards a standard benchmark for variant and gene prioritisation algorithms: PhEval-Phenotypic inference Evaluation framework
    Authors: Y Bridges, V de Souza, KG Cortes, M Haendel, NL Harris, DR Korn, …
    Year: 2024

 

  • Title: Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome
    Authors: V Salpietro, R Maroofian, MS Zaki, J Wangen, A Ciolfi, S Barresi, …
    Year: 2024

 

  • Title: Combined exome analysis and exome depth assessment achieve a high diagnostic yield in an epilepsy case series, revealing significant genomic heterogeneity and novel mechanisms
    Authors: D Veltra, FN Tilemis, NM Marinakis, M Svingou, A Mitrakos, K Kosma, …
    Year: 2023

 

✅ Conclusion

Dr. Nikolaos M. Marinakis stands out as a distinguished researcher in the field of medical genetics and genomics. His work bridges cutting-edge molecular research with clinical diagnostics, making a direct impact on patient care and the understanding of rare diseases. His technical expertise, international collaborations, and growing leadership in genomic diagnostics reflect both his current achievements and his potential for future contributions to precision medicine. He is a strong candidate for recognition in any academic or professional forum honoring excellence in translational genomics and biomedical research.

Fawad Ali Shah | Neuropharmacology |

Posted on by Neuroscientists

Dr. Fawad Ali Shah | Neuropharmacology | Best Researcher Award

Dr. Fawad Ali Shah,  Prince Sattam bin Abdulaziz University, Saudi Arabia.

Dr. Fawad Ali Shah is an accomplished neuroscientist and pharmacologist whose academic journey began with a Pharm-D from the University of Malakand, Pakistan, and culminated in a Ph.D. in Neuroscience and Pharmacology from Gyeongsang National University, South Korea. With a strong foundation in neuroprotective pharmacology, his doctoral and postdoctoral research has focused on natural therapeutic agents for cerebral ischemia and brain injury. Professionally, he has held key academic roles in Pakistan, South Korea, Canada, and Saudi Arabia, currently serving as an Associate Professor at Prince Sattam Bin Abdulaziz University.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Fawad Ali Shah embarked on his academic journey with a profound interest in pharmaceutical sciences and neuroscience. He earned his Doctor of Pharmacy (Pharm-D) degree from the University of Malakand, Khyber Pakhtunkhwa, Pakistan, in 2010 with a First Division and a solid 70.88% score. His thesis, which explored ischemic and reperfusion injuries and their clinical implications, laid a strong foundation for his lifelong dedication to the neuropharmacological sciences. Driven by a deeper quest for knowledge, he pursued his Ph.D. at the esteemed Gyeongsang National University (GNU) in South Korea, where he specialized in neuroscience and pharmacology. Graduating with an A+ average in 2017, his doctoral research focused on investigating the neuroprotective effects of natural drug substances in models of cerebral ischemic injury. This blend of clinical insight and experimental pharmacology set the stage for his career in neuropharmacological research.

🧠 Professional Endeavors in Neuroscience

After earning his doctorate, Dr. Shah’s professional journey took a dynamic course across academia and clinical research institutions. He began as a Research Scholar and Lab Coordinator in the Neurobiology and Brain Histology Lab at GNU, deepening his technical expertise in neurohistology and preclinical pharmacology. Following this, he was appointed as Assistant Professor and then promoted to Associate Professor at Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad. His academic ascent continued with two prestigious postdoctoral positions: a lab-based postdoctoral fellowship at Robarts Research Institute, University of Western Ontario, Canada, and another at the University of Toronto. In 2022, he joined Prince Sattam Bin Abdulaziz University, Saudi Arabia, as an Associate Professor in the Department of Pharmacology and Toxicology. His teaching and mentorship roles have nurtured aspiring pharmacists and neuroscientists alike, while his hands-on work as a former Associate Pharmacist at GlaxoSmithKline (GSK) and Biogenics added vital industry experience to his academic pursuits.

🔬 Research Focus and Scientific Contributions

Dr. Shah’s research is anchored in the exploration of neuroprotective strategies, particularly involving natural drug substances in mitigating cerebral ischemia and related neuronal injuries. His scientific endeavors are characterized by a translational approach—bridging preclinical findings with potential therapeutic implications. Through a series of methodical investigations during his Ph.D. and postdoctoral tenures, he contributed to the understanding of ischemic brain injury mechanisms, drug-induced neuroprotection, and histopathological changes associated with brain trauma. He has significantly advanced the neuropharmacology discipline by contributing original research that addresses real-world health challenges, such as stroke and neurodegenerative conditions. His collaborations in Canadian research institutions have further enriched his methodological expertise and international research exposure.

📚 Teaching Excellence and Academic Impact

As a seasoned academic, Dr. Shah has been instrumental in delivering rigorous pharmacology and toxicology curricula to undergraduate and graduate pharmacy students. His dual role as a researcher and educator has empowered students with both theoretical understanding and laboratory proficiency. His mentorship extends beyond the classroom, guiding research projects and helping students build critical thinking in experimental neuroscience. His affiliation with academic institutions in Pakistan, South Korea, and Saudi Arabia demonstrates his global academic influence and his ability to adapt to diverse educational environments. His role in curriculum development and departmental leadership has contributed to the overall elevation of academic standards wherever he has served.

🏅 Recognition and Accolades

Dr. Fawad Ali Shah is an HEC (Higher Education Commission) Approved Supervisor, a recognition that attests to his academic merit and capability to guide M.Phil. and Ph.D. research. His scholarly distinction, demonstrated by first-class academic performance and international postdoctoral achievements, has earned him esteem in both academic and research circles. His involvement with reputed institutions like the University of Toronto and Robarts Research Institute has positioned him among globally recognized neuroscientists contributing to pharmacological innovation and brain research.

🌍 Global Reach and Influence

Dr. Shah’s academic and research footprints span several continents, including Asia, North America, and the Middle East. His international collaborations and transdisciplinary research have helped forge global scientific alliances. Through participation in international conferences, seminars, and research initiatives, he has disseminated key findings in neuropharmacology and inspired academic exchanges. His commitment to ethical and impactful research, along with his cross-border academic contributions, highlights his role as a globally engaged scholar advancing neuroscience for public health benefits.

🔮 Vision, Legacy, and Future Contributions

Looking ahead, Dr. Shah envisions expanding the therapeutic potential of natural compounds in managing neurodegenerative and cerebrovascular diseases. He aspires to establish advanced neuropharmacology labs in collaboration with global research centers to facilitate translational research and innovative drug discovery. His legacy lies in nurturing a new generation of neuroscientists, fostering research with clinical relevance, and strengthening the bridge between pharmaceutical education and neurological care. With a growing portfolio of impactful publications and international engagements, Dr. Shah is poised to remain a leading voice in neurotherapeutics and pharmacological innovation.

Publication

  1. Title: Carvacrol attenuated haloperidol-induced Parkinson’s disease via TNF/NFκβ-NLRP3-mediated pyroptosis
    Author(s): Not listed
    Year: 2025
    Journal: Laboratory Animal Research

 

  1. Title: In Silico molecular docking and molecular dynamic simulation of transferrin coated Phenytoin loaded SLNs with molecular targets of epilepsy
    Author(s): Not listed
    Year: 2025
    Journal: PLOS ONE

 

  1. Title: Carvacrol attenuated myocardial infarction through NLRP3-mediated pyroptosis and mTOR/Nrf2/PPARÎł-dependent autophagic signaling
    Author(s): Not listed
    Year: 2025
    Journal: Toxicology and Applied Pharmacology

 

  1. Title: Retraction notice to “Quercetin attenuated ischemic stroke induced neurodegeneration by modulating glutamatergic and synaptic signaling pathways”
    Author(s): Not listed
    Year: 2024
    Journal: Heliyon

 

  1. Title: Ghrelin’s modulation of growth hormone secretagogue receptors in primary glioblastoma and meningioma: A comprehensive in-vitro study
    Author(s): Not listed
    Year: 2025
    Journal: Biochemical and Biophysical Research Communications

 

  1. Title: Corrigendum to “pH-Sensitive Tacrolimus loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease”
    Author(s): Not listed
    Year: 2024
    Journal: European Journal of Pharmaceutics and Biopharmaceutics

 

  1. Title: Punicalagin improves inflammation and oxidative stress in rat model of pelvic inflammatory disease
    Author(s): Not listed
    Year: 2025
    Journal: Natural Product Research

 

  1. Title: Core-shell tablets designed for modified and sequential release of ibuprofen and rabeprazole
    Author(s): Not listed
    Year: 2024
    Journal: International Journal of Pharmaceutics

 

  1. Title: Effect of Bacillus clausii in attenuating symptoms of DSS-induced ulcerative colitis by modulating NFkB pathway and oxidative stress in mice
    Author(s): Not listed
    Year: 2024
    Journal: Clinical and Experimental Pharmacology and Physiology

 

  1. Title: Paroxetine Loaded Nanostructured Lipid Carriers Based In-situ Gel for Brain Delivery via Nasal Route for Enhanced Anti-Depressant Effect: In Vitro Prospect and In Vivo Efficacy
    Author(s): Not listed
    Year: 2024
    Journal: AAPS PharmSciTech

 

🧾 Conclusion

Dr. Fawad Ali Shah stands out as a dedicated researcher, educator, and global academic contributor in the fields of neuroscience and pharmacology. His blend of international experience, pioneering research on natural neuroprotective agents, and commitment to academic excellence underscores his significant role in the advancement of neurotherapeutics. As he continues to inspire future scientists and lead innovative research, his impact will resonate across both the scientific and clinical communities, shaping the future of neurological health and pharmaceutical sciences.

William Mills III | Translational Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. William Mills III | Translational Neuroscience | Best Researcher Award

Dr. William Mills III, University of Virginia, United States.

William A. Mills III, known as Tré, is a dedicated neuroscientist whose academic and professional journey reflects a strong commitment to translational and interdisciplinary research. With foundational training from Virginia Tech and international exposure through studies in China, Tré has developed a deep expertise in neurovascular coupling and glial biology. His doctoral and postdoctoral research has significantly advanced our understanding of how microglia and aging influence the brain’s vascular systems. Through prestigious fellowships and awards, including the NIH K99/R00 and the AHA Postdoctoral Fellowship, Tré has proven his potential to become a leading figure in neuroscience. His work bridges multiple scientific disciplines and focuses on uncovering mechanisms that contribute to neurological aging and disease.

Profile

Google Scholar

🎓 Early Academic Pursuits

William A. Mills III, fondly known as Tré, laid a solid foundation for his scientific career through rigorous and diverse academic training. He earned his Bachelor of Science degree in Biological Sciences from Virginia Tech in 2014, where he was actively involved in research labs focusing on virology, behavioral ecology, and disease ecology. His passion for cross-cultural and interdisciplinary learning was evident as he pursued Chinese language studies at Xi’an Jiaotong-Liverpool University from 2014 to 2015. This global academic exposure was followed by his Ph.D. in Translational Biology, Medicine & Health with a neuroscience focus at Virginia Tech (2015–2021), where he developed a strong interest in neurovascular and glial biology. These formative experiences created a well-rounded and curious scientist ready to tackle complex biomedical questions.

🧠 Professional Endeavors in Neuroscience

TrĂŠ’s professional journey took a pivotal turn when he joined the Eyo Lab at the University of Virginia as a Postdoctoral Research Fellow in 2021. His research investigates the intricate role of microglia in regulating capillary basal tone and neurovascular coupling—an area that sits at the intersection of neuroimmunology and vascular biology. His graduate years in the Sontheimer Lab had already shaped his expertise in glial signaling pathways, particularly focusing on the effects of aging on gliovascular interactions involving EGFR and pSTAT3. These experiences underscore a continuous commitment to understanding the cellular mechanisms that underpin brain function and disease.

🧪 Contributions and Research Focus

Throughout his research career, TrĂŠ has contributed significantly to the field of neurovascular biology and glial cell research. His scientific curiosity has spanned from studying the cellular mechanics of viral encapsidation in early projects to evaluating semaphorin roles in cardiovascular pathology. Notably, his doctoral work on gliovascular plasticity and his current postdoctoral focus on microglia’s role in cerebral blood flow regulation highlight his interdisciplinary approach. By bridging neuroscience, immunology, and vascular biology, he is shedding light on the fundamental processes that maintain brain health and how their disruption leads to age-related and neurodegenerative diseases.

🏅 Accolades and Recognition

Tré’s outstanding research potential has been recognized by several prestigious institutions. He was awarded the American Heart Association Career Development Award (which he respectfully declined), the American Heart Association Postdoctoral Fellowship (25POST1376070), and the UVA Brain Institute Postdoctoral Research Fellowship. In addition, he secured training support through the UVA Cardiovascular Research Center T32 Training Grant, reflecting the strong institutional belief in his capabilities. Most notably, he earned the competitive NIH K99/R00 Pathway to Independence Award, a mark of distinction for early-career researchers poised to transition to faculty positions.

🔬 Impact and Influence in Translational Neuroscience

Tré’s research contributions are highly translational in nature, linking basic cellular mechanisms to potential therapeutic implications in aging, stroke, and neurodegeneration. His work on microglial function in neurovascular coupling could provide new insights into how blood flow dysregulation contributes to cognitive decline and dementia. By exploring how aging alters glial and vascular interactions, Tré’s research holds the promise to inform interventions targeting the brain’s support systems to preserve function in aging populations. His influence is also visible through collaborative projects, lab mentorship, and participation in international research endeavors.

🌍 Legacy and Future Contributions

Looking ahead, TrĂŠ is poised to leave a lasting legacy in the field of neurovascular biology. With a trajectory marked by intellectual rigor, global awareness, and translational relevance, he is expected to lead pioneering studies that will redefine our understanding of brain support systems in health and disease. The foundation laid by his NIH K99/R00 award positions him well to establish an independent research program, where he will likely mentor future scientists and push the boundaries of neuroscience through integrative and innovative research methodologies.

🧬 A Champion of Interdisciplinary Science

A defining trait of Tré’s career is his seamless integration of diverse scientific fields—ranging from immunology and neuroscience to cardiovascular biology and behavioral ecology. This interdisciplinary ethos not only enriches his research output but also positions him as a bridge-builder in science, capable of uniting different perspectives to address complex biomedical challenges. His academic journey from microbiology and animal behavior to glial biology exemplifies a dynamic scientist committed to evolving with the science, while remaining grounded in his passion for discovery.

Publication

  • Title: Capillary-associated microglia regulate vascular structure and function through PANX1-P2RY12 coupling in mice
    Authors: K. Bisht, K.A. Okojie, K. Sharma, D.H. Lentferink, Y.Y. Sun, H.R. Chen, …
    Year: 2021

 

  • Title: Spatially expandable fiber-based probes as a multifunctional deep brain interface
    Authors: S. Jiang, D.C. Patel, J. Kim, S. Yang, W.A. Mills III, Y. Zhang, K. Wang, Z. Feng, …
    Year: 2020

 

  • Title: Astrocyte plasticity in mice ensures continued endfoot coverage of cerebral blood vessels following injury and declines with age
    Authors: W.A. Mills III, A.L.M. Woo, S. Jiang, J. Martin, D. Surendran, M. Bergstresser, …
    Year: 2022

 

  • Title: Lactobacillus rescues postnatal neurobehavioral and microglial dysfunction in a model of maternal microbiome dysbiosis
    Authors: Y. Lebovitz, E.A. Kowalski, X. Wang, C. Kelly, M. Lee, V. McDonald, R. Ward, …
    Year: 2019

 

  • Title: Potassium and glutamate transport is impaired in scar-forming tumor-associated astrocytes
    Authors: S.C. Campbell, C. MuĂąoz-Ballester, L. Chaunsali, W.A. Mills III, J.H. Yang, …
    Year: 2020

 

  • Title: LRRTM1 underlies synaptic convergence in visual thalamus
    Authors: A. Monavarfeshani, G. Stanton, J. Van Name, K. Su, W.A. Mills III, K. Swilling, …
    Year: 2018

 

  • Title: EphA4/Tie2 crosstalk regulates leptomeningeal collateral remodeling following ischemic stroke
    Authors: B. Okyere, W.A. Mills, X. Wang, M. Chen, J. Chen, A. Hazy, Y. Qian, J.B. Matson, …
    Year: 2020

 

  • Title: Nano-optoelectrodes integrated with flexible multifunctional fiber probes by high-throughput scalable fabrication
    Authors: S. Jiang, J. Song, Y. Zhang, M. Nie, J. Kim, A.L. Marcano, K. Kadlec, …
    Year: 2021

 

  • Title: The emergence of the calvarial hematopoietic niche in health and disease
    Authors: W.A. Mills III, M.A. Coburn, U.B. Eyo
    Year: 2022

 

  • Title: Using zebrafish to elucidate glial-vascular interactions during CNS development
    Authors: R.A. Umans, C. Pollock, W.A. Mills III, K.C. Clark, Y.A. Pan, H. Sontheimer
    Year: 2021

 

🧾 Conclusion

TrĂŠ stands out as a forward-thinking and highly skilled researcher whose contributions are shaping the future of neurovascular and glial research. His innovative approach, academic excellence, and recognition by top funding agencies underscore his suitability for leadership roles in neuroscience. As he transitions into an independent research career, TrĂŠ is expected to make enduring impacts on the scientific community through groundbreaking discoveries, mentorship, and interdisciplinary collaboration. His trajectory is a testament to his dedication, curiosity, and potential to transform brain health research.

Ling-Yan Su | Molecular Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. Ling-Yan Su | Molecular Neuroscience | Best Researcher Award

Dr. Ling-Yan Su, Yunnan Agricultural University, China.

Professor Ling-Yan Su is a leading figure in the field of food science and plant physiology, currently serving at the College of Food Science and Technology, Yunnan Agricultural University. With a solid academic foundation from Yunnan University and the Chinese Academy of Sciences, she has built a dynamic career that bridges molecular biology and applied agricultural research. Her pioneering work on melatonin-based pre-harvest treatments has significantly advanced our understanding of natural preservation techniques, especially in prolonging the post-harvest life and quality of fruits like Myrica rubra. Her research focuses on enhancing antioxidant systems, inhibiting spoilage, and activating plant defense pathways through sustainable, low-toxicity treatments.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Ling-Yan Su’s journey in the biological sciences began with a Bachelor of Science degree from the School of Life Science at Yunnan University (2007–2011). Demonstrating academic curiosity and determination early on, she expanded her horizons through a year-long visiting student program (2010–2011) at the prestigious Kunming Institute of Zoology, affiliated with the Chinese Academy of Sciences. This experience laid the foundation for her doctoral research, which she pursued at the same institute from 2011 to 2017, where she rigorously explored complex biological systems, further solidifying her passion for food science and plant physiology.

🧪 Professional Endeavors in Science

Professor Su’s professional career has been marked by consistent growth across esteemed academic institutions. Following her Ph.D., she joined the Kunming Institute of Zoology as a research assistant, rapidly advancing to the role of associate professor. In 2022, she transitioned to the College of Food Science and Technology at Yunnan Agricultural University, initially as an associate professor before her promotion to full professor within the same year. Her academic trajectory reflects a blend of deep research engagement and an evolving role in shaping food science education and innovation in China.

🌿 Contributions and Research Focus

Professor Su’s groundbreaking work lies at the intersection of plant physiology, post-harvest fruit biology, and food preservation technology. She has made significant contributions to understanding how melatonin, a naturally occurring compound, can be leveraged to extend the post-harvest shelf life of Myrica rubra (Chinese bayberry). Her studies demonstrate that melatonin pre-harvest treatments reduce oxidative stress markers, inhibit microbial decay, and activate the phenylpropanoid pathway, resulting in elevated antioxidant activity. This line of research not only reveals novel mechanisms of fruit preservation but also opens sustainable avenues in post-harvest biology and food safety.

🏅 Accolades and Recognition

While formal awards are not listed, Professor Su’s rapid academic promotions and appointments at prestigious research institutes such as the Chinese Academy of Sciences and Yunnan Agricultural University underscore her recognition within the scientific community. Her work is contributing to a growing body of literature on sustainable food science innovations, earning her esteem among peers and collaborators in the agricultural biotechnology field.

🌱 Impact and Influence

Professor Su’s innovative application of melatonin in fruit preservation has substantial implications for food technology and agricultural practices. Her research directly addresses global concerns such as food spoilage, post-harvest losses, and chemical-free preservation methods. By enhancing natural antioxidant defenses and inhibiting spoilage at a molecular level, her work supports both farmers and consumers in accessing healthier and longer-lasting produce, especially within the context of environmentally conscious food systems.

🔬 Legacy in Food Science

The legacy Professor Su is building centers around translating scientific inquiry into practical solutions for real-world agricultural challenges. Her research is charting a course for future studies in the bio-preservation of fruits and vegetables using natural treatments. As she continues to mentor students and collaborate across disciplines, her influence is extending into the next generation of food scientists and researchers focused on plant biochemistry, post-harvest technology, and sustainable agricultural innovation.

🚀 Future Contributions and Vision

Looking ahead, Professor Ling-Yan Su is poised to further explore how endogenous compounds like melatonin can be applied across various fruits and food crops. Her vision includes broadening the scope of natural food preservation strategies and delving deeper into molecular pathways that regulate plant defense responses. As a respected academic and scientist, her future contributions are expected to shape healthier food systems and deepen scientific understanding of plant–microbe–compound interactions.

Publication

  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
    Authors: DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, …
    Year: 2021

 

  • Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model
    Authors: R Luo, LY Su, G Li, J Yang, Q Liu, LX Yang, DF Zhang, H Zhou, M Xu, …
    Year: 2020

 

  • Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/Îą-synuclein aggregation
    Authors: LY Su, H Li, L Lv, YM Feng, GD Li, R Luo, HJ Zhou, XG Lei, L Ma, JL Li, …
    Year: 2015

 

  • Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin
    Authors: YM Feng, YF Jia, LY Su, D Wang, L Lv, L Xu, YG Yao
    Year: 2013

 

  • Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China
    Authors: D Wang, L Xu, L Lv, LY Su, Y Fan, DF Zhang, R Bi, D Yu, W Zhang, XA Li, …
    Year: 2015

 

  • Atg5- and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine
    Authors: LY Su, R Luo, Q Liu, JR Su, LX Yang, YQ Ding, L Xu, YG Yao
    Year: 2017

 

  • Positive selection rather than relaxation of functional constraint drives the evolution of vision during chicken domestication
    Authors: MS Wang, R Zhang, LY Su, Y Li, MS Peng, HQ Liu, L Zeng, DM Irwin, …
    Year: 2016

 

  • Melatonin alleviates morphine analgesic tolerance in mice by decreasing NLRP3 inflammasome activation
    Authors: Q Liu, LY Su, C Sun, L Jiao, Y Miao, M Xu, R Luo, X Zuo, R Zhou, P Zheng, …
    Year: 2020

 

  • Out of Southern East Asia of the brown rat revealed by large-scale genome sequencing
    Authors: L Zeng, C Ming, Y Li, LY Su, YH Su, NO Otecko, A Dalecky, S Donnellan, …
    Year: 2018

 

  • Moringa oleifera Lam. leaves as new raw food material: A review of its nutritional composition, functional properties, and comprehensive application
    Authors: M Yang, L Tao, XR Kang, ZL Wang, LY Su, LF Li, F Gu, CC Zhao, J Sheng, …
    Year: 2023

 

✅ Conclusion

Professor Su’s academic journey and research contributions exemplify scientific excellence rooted in sustainability and innovation. Her work not only provides practical solutions to post-harvest challenges but also contributes to broader efforts in reducing food waste and promoting natural preservation methods. As she continues to mentor young researchers and expand her studies, Professor Su is well-positioned to leave a lasting impact on food science and agricultural biotechnology. Her career reflects a thoughtful integration of research, application, and forward-looking vision in the quest for healthier and more resilient food systems.

Ali Nouri | Neuroscience & Education | Best Researcher Award

Posted on by Neuroscientists

Assoc. Prof. Dr. Ali Nouri | Neuroscience & Education | Best Researcher Award

Assoc. Prof. Dr. Ali Nouri Malayer, University, Iran.

Dr. Ali Nouri is an accomplished Associate Professor at Malayer University with a Ph.D. in Curriculum and Instruction and postdoctoral training in cognitive science from Lund University. His academic and research journey bridges the fields of curriculum studies and educational neuroscience, focusing on the neurocognitive foundations of learning, instructional design, and educational neurotechnology. With over 50 published journal articles, one major book, and leadership in more than 17 research projects at various levels, Dr. Nouri has played a pivotal role in shaping the emerging field of Educational Neuroscience. He is also the director of a Cognitive Science Laboratory, serves on editorial boards of leading journals, and actively participates in global academic collaborations. His research is highly cited, and he is a recognized figure in both national and international academic communities.

Profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Ali Nouri began his academic journey with a deep curiosity about how humans learn and how education systems can be enhanced through scientific insight. He pursued his Ph.D. in Curriculum and Instruction from the prestigious Tarbiat Modares University in 2012, laying a strong theoretical foundation in curriculum studies. His passion for integrating brain science into education led him to undertake a sabbatical training in Cognitive Science at Lund University, Sweden—a formative experience that expanded his expertise into interdisciplinary domains, combining educational theory with neuroscience.

👨‍🏫 Professional Endeavors

Currently serving as an Associate Professor at Malayer University, Dr. Nouri is a committed educator and researcher in the Educational Sciences Department. His professional path includes teaching engagements at the Institute for Cognitive Studies and leadership roles such as directing the Neuroeducation Studies Special Interest Group (SIG) under the Iranian Curriculum Studies Association. His work embodies a hybrid identity—as both a curriculum theorist and a neuroscientist—bridging pedagogical design and neural science.

🧠 Contributions and Research Focus

Dr. Nouri’s research centers on the neurocognitive foundations of learning, the neuroscientific underpinnings of curriculum, and instructional design. With a visionary approach, he integrates neurotechnology, particularly AI-supported educational tools, into learning environments. Through his work, he seeks to revolutionize how learning is conceptualized and delivered by translating neuroscience insights into practical curriculum strategies. His significant contributions have helped solidify Educational Neuroscience as a legitimate field of academic inquiry and application.

📚 Research Projects and Scholarly Output

Dr. Nouri has successfully led 3 international, 4 national, and 10 institutional-level research projects, highlighting his consistent engagement with innovation and development in neuroeducation. His scholarly record includes over 50 peer-reviewed journal articles, contributions to book publications, and numerous conference papers. His co-authored book, Crossing Mind, Brain, and Education Boundaries (ISBN: 978-1-5275-9075-5), underscores his interdisciplinary outlook. His Google Scholar citation index of 723 and Scopus citations of 78 further reflect the reach and credibility of his academic work.

🧪 Innovation, Collaboration, and Editorial Leadership

In addition to his academic roles, Dr. Nouri has provided consultancy on 8 industry-related projects, underscoring the practical impact of his work. He is also the Principal Investigator and Director of the Cognitive Science Laboratory, fostering collaborative inquiry into educational technologies and brain research. He serves on the editorial boards of leading journals like Dialogic Pedagogy and IJCRSEE, and actively participates in academic discourse through more than 10 international conferences. His affiliations with global bodies like the American Educational Research Association and various national groups reflect his active engagement with the global academic community.

🏆 Accolades and Recognition

Although Dr. Nouri’s contributions are more reflected in impact than in awards, his roles as a research leader, keynote speaker, and academic collaborator have earned him wide respect within scholarly circles. His ability to cross disciplinary boundaries, innovate teaching strategies, and publish rigorously in reputable outlets places him among the leading voices shaping the field of neuroeducation today.

🔮 Legacy and Future Contributions

Dr. Nouri’s academic journey is far from over. His commitment to expanding the field of educational neurotechnology—including AI and brain-computer interfaces—promises transformative contributions in years to come. As an educator, researcher, and leader, he is poised to further influence the integration of neuroscience into classroom practice, teacher training, and policy formation. His legacy is likely to be defined by his pioneering work in constructing neuroeducational methodologies, empowering future scholars and practitioners to build a scientifically grounded and cognitively responsive educational system.

Publication

  • Emancipatory Pedagogy in Practice: Aims, Principles and Curriculum Orientation
    A. Nouri, S.M. Sajjadi — 2014

 

  • Defining the Boundaries for Neuroeducation as a Field of Study
    A. Nouri, M. Mehrmohammadi — 2012

 

  • The Basic Principles of Research in Neuroeducation Studies
    A. Nouri — 2016

 

  • Making Neuroscience a Priority in Initial Teacher Education Curricula: A Call for Bridging the Gap Between Research and Future Practices in the Classroom
    A. Sortwell, E. Gkintoni, S. Zagarella, U. Granacher, P. Forte, R. Ferraz, … — 2023

 

  • Expectations of Institutionalized Elderly from Their Children
    A. Nouri, S. Farsi — 2018

 

  • Evaluating What Mind, Brain and Education Has Taught Us
    T. Tokuhama-Espinosa, A. Nouri — 2020

 

  • Foundations of Cognitive Education: Issues and Opportunities
    M. Talkhabi, A. Nouri — 2012

 

  • An Adaptable, Open-Access Test Battery to Study the Fractionation of Executive-Functions in Diverse Populations
    G.A.V. Zanini, M.C. Miranda, H. Cogo-Moreira, A. Nouri, A.L. FernĂĄndez, … — 2021

 

  • Practical Strategies for Enhancing Interdisciplinary Collaboration in Neuroeducational Studies
    A. Nouri — 2013

 

  • Dialogic Learning: A Social Cognitive Neuroscience View
    A. Nouri — 2014

 

🧾 Conclusion

Dr. Nouri exemplifies interdisciplinary excellence, combining deep theoretical expertise in curriculum development with cutting-edge insights from cognitive neuroscience. His pioneering work has helped define Educational Neuroscience as both an academic field and a practical discipline. Through ongoing research, leadership, and collaboration, he continues to influence the future of education by integrating brain-based strategies and neurotechnology into learning environments. His legacy is marked by innovation, scholarly rigor, and a visionary commitment to transforming education through science.

Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Dr. Antonella Santuccione Chadha, Women` s Brain Foundation,  Switzerland.

Dr. Antonella Chadha Santuccione is a highly accomplished clinical pathologist, neuroscientist, and executive leader with notable expertise in clinical trial management and cognitive behavioral therapy. Born in Italy and based in Switzerland, she has held executive roles and board memberships across biotech and healthcare organizations. She is also the founder and pro-bono CEO of the Women’s Brain Foundation, emphasizing her commitment to neuroscience and gender-specific brain health.

Profile

Scopus
Orcid

📚 Early Academic Pursuits

Dr. Antonella Chadha Santuccione’s academic foundation is deeply rooted in medical science and behavioral therapy, reflecting her passion for understanding the human mind and body. Born on June 13, 1974, in Penne, Italy, she pursued her education in medicine, earning her MD with specialization in Clinical Pathology. Furthering her academic rigor, she attained credentials from FMH and MEBEKO and completed a CAS in Clinical Trial Management. With an eye toward holistic care and human psychology, she expanded her studies to include Cognitive Behavioral Therapy. Her diverse training laid the groundwork for a multifaceted approach to clinical neuroscience, bridging biology, diagnostics, and therapeutic psychology.

🧪 Professional Endeavors

Throughout her professional journey, Dr. Santuccione has combined her clinical acumen with entrepreneurial vision. After relocating to Switzerland, she took on advisory roles in several neuro-focused start-ups including Bottneuro, Altoida, Pipra, ReconnectLab, and EqualCare, where she played a pivotal role in aligning scientific discovery with patient-centered innovation. Serving as an Executive Director and Board Member across multiple initiatives, she brought together cross-disciplinary teams to push the frontiers of diagnostics and digital health. Her pro-bono leadership as the Founder and CEO of the Women’s Brain Foundation further demonstrates her commitment to addressing gender disparities in brain health research and care.

🧠 Contributions and Research Focus

Dr. Santuccione’s work focuses on the intersection of neuroscience, gender-specific medicine, and clinical innovation. Her research advocacy highlights the importance of considering sex differences in neurodegenerative diseases such as Alzheimer’s, a field historically underexplored. By promoting personalized approaches to brain health, she has helped shape how researchers and clinicians think about prevention, diagnosis, and treatment across genders. Her insights into cognitive decline, early diagnostic markers, and patient-centric treatment frameworks have influenced both academic thought and clinical practice. Additionally, her work in start-ups integrates AI and data-driven technologies to monitor cognitive health, marking her as a forerunner in digital neuroscience.

🏅 Accolades and Recognition

Dr. Santuccione’s contributions have earned her widespread acclaim both within Switzerland and internationally. She was selected among the Top 100 Business Women in Switzerland from 2018 to 2023, a testament to her sustained influence in science and innovation. In 2019, she was named Woman of the Year by Women in Business CH through a public election, highlighting her societal impact beyond the scientific community. The World Sustainability Award in 2020 and the Bold Women Award Switzerland in 2022 recognized her efforts in building ethical, inclusive scientific models. Most recently, she received the Empowering Women Award 2024 and was featured among the Women to Watch 2025, celebrating her as a role model for future leaders.

🌍 Impact and Influence

Beyond her clinical and scientific achievements, Dr. Santuccione has become a global advocate for change in the healthcare landscape. Her work challenges the traditional silos of medicine, psychology, and technology, offering integrative solutions that are ethical and inclusive. She has empowered countless women in STEM through her foundation, speaking engagements, and mentorship programs. Her influence extends into public policy discussions and public health awareness campaigns, where she brings attention to the need for gender equity and individualized treatment in brain disorders. She is not only a scientist but a communicator who bridges science and society.

💡 Legacy and Future Contributions

Dr. Antonella Chadha Santuccione is a trailblazer shaping the next era of neuroscience through compassion-driven research and visionary leadership. Her legacy lies in her determination to dismantle systemic barriers in medicine—especially those that affect women—and in creating frameworks where innovation serves the individual. With ongoing roles in biotech leadership, nonprofit work, and public advocacy, she is set to further influence global conversations around brain health, mental wellness, and gendered research. Her career is a beacon for aspiring researchers who believe that science should serve humanity with empathy, precision, and equity.

🧬 A Champion for Brain Science and Humanity

Dr. Santuccione embodies the rare synthesis of scientific brilliance, leadership excellence, and humanitarian vision. Her work underscores a commitment to better understanding the human brain—not only through the lens of pathology, but also through the lens of experience, gender, and empathy. As she continues her journey, she stands as a symbol of what it means to be a 21st-century neuroscientist: grounded in evidence, driven by innovation, and devoted to people.

Publication

1. Title: Women’s brain health and brain capital
Authors: Laura Castro-Aldrete, Megan Greenfield, Erin Smith, Harris A. Eyre, Mariapaola Barbato, Lucy PĂŠrez, Antonella Santuccione Chadha
Year: 2025

2. Title: Abortion and Miscarriage on Twitter: Sentiment and Polarity Analysis from a gendered perspective
Authors: Olivier Philippe, MarĂ­a Flores Rodero, Claire Yohalem Furtick, Laura Planas SimĂłn, Maria Teresa Ferretti, Antonella Santuccione Chadha, Laia Subirats MatĂŠ, Davide Cirillo, MarĂ­a JosĂŠ Rementeria
Year: 2024

3. Title: Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts
Authors: Matamoros-Angles A, Mohammadi B, Song F, Shafiq M, Brenna S, Puig B, Glatzel M, Altmeppen HC
Year: 2023

4. Title: Global synergistic actions to improve brain health for human development
Authors: Owolabi MO, Leonardi M, Bassetti C, Jaarsma J, Hawrot T, Makanjuola AI, Dhamija RK, Feng W, Straub V, Camaradou J, et al.
Year: 2023

5. Title: Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution
Authors: Laura Castro-Aldrete, Moser MV, Putignano G, Ferretti MT, Schumacher Dimech A, Antonella Santuccione Chadha
Year: 2023

6. Title: Towards AI-driven longevity research: An overview
Authors: Marino N, Putignano G, Cappilli S, Chersoni E, Antonella Santuccione Chadha, Calabrese G, Bischof E, Vanhaelen Q, Zhavoronkov A, Scarano B
Year: 2023

7. Title: Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
Authors: Pfundstein G, Nikonenko AG, Sytnyk V
Year: 2022

8. Title: Prions induce an early Arc response and a subsequent reduction in mGluR5 in the hippocampus
Authors: Ojeda-JuĂĄrez D, Lawrence JA, Soldau K, Pizzo DP, Wheeler E, Aguilar-Calvo P, Khuu H, Chen J, Malik A, Funk G, et al.
Year: 2022

9. Title: Digital biomarkers and sex impacts in Alzheimer’s disease management – potential utility for innovative 3P medicine approach
Authors: Harms RL, Ferrari A, Meier IB, Martinkova J, Santus E, Marino N, Cirillo D, Mellino S, Catuara Solarz S, Tarnanas I, et al.
Year: 2022

🏁 Conclusion

Dr. Antonella Chadha Santuccione’s career is a model of interdisciplinary excellence, innovation, and advocacy. Her ability to blend neuroscience research with executive leadership and public engagement sets her apart as a visionary in brain health. She not only advances the scientific understanding of neurodegeneration but also actively reshapes how gender and equity are addressed in medical research. With a lasting legacy in both scientific and humanitarian domains, she is exceptionally well-suited for high-level recognition such as the Best Researcher Award and remains a powerful voice shaping the future of neuroscience globally.